BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16822721)

  • 1. Diabetes and cardiovascular disease. Introduction.
    Chait A
    Atheroscler Suppl; 2006 Aug; 7(4):1-4. PubMed ID: 16822721
    [No Abstract]   [Full Text] [Related]  

  • 2. Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.
    Quispe R; Martin SS; Jones SR
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):150-6. PubMed ID: 26863278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering.
    Mayer-Davis EJ; Ma B; Lawson A; D'Agostino RB; Liese AD; Bell RA; Dabelea D; Dolan L; Pettitt DJ; Rodriguez BL; Williams D;
    Metab Syndr Relat Disord; 2009 Apr; 7(2):89-95. PubMed ID: 18847385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome.
    Opie LH
    Circulation; 2007 Jan; 115(3):e32-5. PubMed ID: 17242286
    [No Abstract]   [Full Text] [Related]  

  • 5. American College of Endocrinology position statement on the insulin resistance syndrome.
    Einhorn D; Reaven GM; Cobin RH; Ford E; Ganda OP; Handelsman Y; Hellman R; Jellinger PS; Kendall D; Krauss RM; Neufeld ND; Petak SM; Rodbard HW; Seibel JA; Smith DA; Wilson PW
    Endocr Pract; 2003; 9(3):237-52. PubMed ID: 12924350
    [No Abstract]   [Full Text] [Related]  

  • 6. The metabolic syndrome in type 2 diabetic subjects in Gorgan, Iran.
    Marjani A; Mojerloo M
    J Pak Med Assoc; 2011 May; 61(5):458-61. PubMed ID: 22204179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk.
    Salazar MR; Carbajal HA; Espeche WG; Dulbecco CA; Aizpurúa M; Marillet AG; Echeverría RF; Reaven GM
    Diab Vasc Dis Res; 2011 Apr; 8(2):109-16. PubMed ID: 21562062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lipid triad, or how to reduce residual cardiovascular risk?
    Girard-Mauduit S
    Ann Endocrinol (Paris); 2010 Mar; 71(2):89-94. PubMed ID: 20303470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview.
    Amihăesei IC; Chelaru L
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity.
    Cruz ML; Weigensberg MJ; Huang TT; Ball G; Shaibi GQ; Goran MI
    J Clin Endocrinol Metab; 2004 Jan; 89(1):108-13. PubMed ID: 14715836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic syndrome: protective obesity].
    Nau JY
    Rev Med Suisse; 2010 Mar; 6(241):644-5. PubMed ID: 20408371
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence.
    Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y
    Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus.
    Hodge AM; Dowse GK; Zimmet PZ
    Diabet Med; 1996 May; 13(5):441-9. PubMed ID: 8737026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
    Sacks FM
    Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
    [No Abstract]   [Full Text] [Related]  

  • 15. Obesity indices and major components of metabolic syndrome in young adult Arab subjects.
    Al-Shayji IA; Akanji AO
    Ann Nutr Metab; 2004; 48(1):1-7. PubMed ID: 14639040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
    Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proinsulin as marker -- what for?].
    Kayser T
    Dtsch Med Wochenschr; 2005 Apr; 130(14):903. PubMed ID: 15800827
    [No Abstract]   [Full Text] [Related]  

  • 18. Obesity, metabolic syndrome, and cardiovascular disease.
    Grundy SM
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2595-600. PubMed ID: 15181029
    [No Abstract]   [Full Text] [Related]  

  • 19. Use it or lose it: exercise, diabetes and CVD.
    Gottlieb SH
    Diabetes Forecast; 2002 May; 55(5):39-41. PubMed ID: 14964157
    [No Abstract]   [Full Text] [Related]  

  • 20. The Editor's Roundtable: the metabolic syndrome.
    Friedewald VE; Grundy S; Gotto AM; Haffner S; Denke MA; Hollander P; Roberts WC
    Am J Cardiol; 2007 Feb; 99(3):382-9. PubMed ID: 17261403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.